Poly Medicure Ltd
NSE: POLYMED BSE: 531768
₹1333.40
(3.88%)
Sun, 15 Mar 2026, 09:21 am
Market Cap130.32B
PE Ratio38.89
Dividend0.27
Health Technology
Medical Specialties
24.5KPoly Medicure Analysis
dividend
- Dividends per share have increased over the past 10 years.
- Dividends paid are well covered by earnings (5.4x coverage).
- Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
- Poly Medicure's pays a lower dividend yield than the bottom 25% of dividend payers in India (0.76%).
- Poly Medicure's dividend is below the markets top 25% of dividend payers in India (3.08%).
health
- Poly Medicure is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
- Poly Medicure is profitable, therefore cash runway is not a concern.
- Poly Medicure is profitable, therefore cash runway is not a concern.
- Debt is well covered by operating cash flow (77.9%, greater than 20% of total debt).
- Debt is covered by short term assets, assets are 1.9x debt.
- Poly Medicure's cash and other short term assets cover its long term commitments.
- The level of debt compared to net worth has been reduced over the past 5 years (40.1% vs 38.5% today).
- Interest payments on debt are well covered by earnings (EBIT is 6.7x coverage).
- Poly Medicure's level of debt (38.5%) compared to net worth is satisfactory (less than 40%).
- High level of physical assets or inventory.
management
- The average tenure for the Poly Medicure board of directors is over 10 years, this suggests they are a seasoned and experienced board.
- Himanshu's compensation has been consistent with company performance over the past year, both up more than 20%.
- Himanshu's remuneration is higher than average for companies of similar size in India.
misc
- Poly Medicure is not covered by any analysts.
- Poly Medicure has significant price volatility in the past 3 months.
past
- Poly Medicure's 1-year earnings growth exceeds its 5-year average (46.4% vs 10.5%)
- Poly Medicure's year on year earnings growth rate has been positive over the past 5 years.
- Poly Medicure used its assets more efficiently than the IN Medical Equipment industry average last year based on Return on Assets.
- Poly Medicure has improved its use of capital last year versus 3 years ago (Return on Capital Employed).
- Poly Medicure has efficiently used shareholders’ funds last year (Return on Equity greater than 20%).
- Poly Medicure's earnings growth has exceeded the IN Medical Equipment industry average in the past year (46.4% vs 21.7%).
value
- 531768 matched the Medical Equipment industry (60.7%) over the past year.
- 531768 outperformed the Market in India which returned -14.5% over the past year.
- Poly Medicure's share price is above the future cash flow value, it's not available at a moderate discount (< 20%).
- Poly Medicure's share price is above the future cash flow value, it's not available at a substantial discount (< 40%).
- Poly Medicure is overvalued based on assets compared to the IN Medical Equipment industry average.
- Poly Medicure is overvalued based on earnings compared to the IN Medical Equipment industry average.
- Poly Medicure is overvalued based on earnings compared to the India market.
- BSE:531768 is up 2.9% underperforming the Medical Equipment industry which returned 9.6% over the past month.
- BSE:531768 is up 2.9% underperforming the market in India which returned 8% over the past month.
Open Your Free Demat Account Now!
Facebook
Twitter
Instagram
LinkedIn
Youtube
Calculators
Popular Calculators
Group Stocks
Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800